Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, University of Cambridge Team on AI-Based Precision Oncology

NEW YORK – GE Healthcare said Monday that it is joining with the University of Cambridge and Cambridge University Hospitals in the UK to develop an artificial intelligence-based application for precision cancer care.

The collaboration, which builds on earlier work at Cambridge supported by the Mark Foundation for Cancer Research and Cancer Research UK, will apply machine learning and other advanced software engineering techniques to produce this app. The partners will seek to integrate clinical, imaging, and genomic data from multiple sources into a single interface for oncologists, surgeons, radiologists, pathologists, and clinical nurse specialists to create personalized treatment plans for each patient.

Initially, GE Healthcare and Cambridge will evaluate the technology in ovarian cancer. They eventually hope to apply their creation across the UK and beyond.

"Bringing all this data together to make precise and informed decisions for patients can be hard. We often do this inefficiently and miss important connections between the data," Richard Gilbertson, director of the Cancer Research UK Cambridge Centre and head of oncology at the University of Cambridge, said in a statement.

"Aggregating and analyzing the substantial amounts of data available would help address an unmet need. Ovarian cancer is an important and complex disease with poor outcomes, and we believe this application would help us deal with its complexity," added James Brenton, professor of ovarian cancer medicine and a senior group leader at the Cancer Research UK Cambridge Institute. Brenton is also co-leader of the Mark Foundation Institute for Integrated Cancer Medicine.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.